Metrion Biosciences are sponsoring and exhibiting (booth number to be added at a later date) at the RSC Ion Channel Symposium taking place from Monday 24th- Tuesday 25th February 2020 at the Wellcome Trust Genome Campus Conference Centre, Hinxton, Cambridge. Metrion will also be presenting a poster (title to be added at a later date).
Metrion’s Business Manager, Dr John Ridley and CSO, Dr Marc Rogers will be attending the event and will be available for discussions regarding Metrion’s ion channel screening services. Please email firstname.lastname@example.org if you would like to arrange a meeting.
Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.